KBI Biopharma Inc., a leading contract development and manufacturing organisation (CDMO), is headquartered in the United States, with significant operational facilities across Europe and Asia. Founded in 1996, KBI has established itself as a key player in the biopharmaceutical industry, specialising in the development and production of biologics, including monoclonal antibodies and recombinant proteins. KBI Biopharma is renowned for its innovative approach to bioprocess development and its commitment to quality, offering a comprehensive suite of services from early-stage development to commercial manufacturing. The company’s state-of-the-art facilities and experienced team enable it to deliver tailored solutions that meet the unique needs of its clients. With a strong market position and a track record of successful partnerships, KBI Biopharma continues to drive advancements in biopharmaceutical manufacturing, contributing to the growth of the industry.
We don't have data for KBI Biopharma Inc, but we can show you information about their parent organization instead.
View parent company